Proper Joint Care Cardiovascular health Immunity Allergy

HOME > Research



Animal StudyⅠ(6)
Lin, B.F. (2002) fed animal subjects with either ordinary skim milk (control group) or S100 MPC (experimental group). After six weeks' feeding, researchers measured and compared various immune system biomarkers in the two groups(6). From the data obtained from this animal study, we can conclude that S100 MPC functions to promote a healthy immune system by promoting the generation of IgA antibodies (Fig. 2), regulating the function of T cells (reducing IL-4 production while increasing IFN-γ production), promoting the differentiation of T-cells towards a Th1 phenotype and increasing the activity of NK cells (Fig. 3).

Fig. 2. Production of IgA was increased, which leads to stronger mucosal immune defenses in the treatment group(5). * p<0.05

Fig. 3. Activity of NK cells in the treatment group was increased(6). * p<0.05


Animal Study Ⅱ(8)

Ishida et al. (1992) fed animal subjects with either ordinary skim milk (control group) or S100 Milk (treatment group) for 7-days prior to irradiation and for the duration of the study. Following the 7-day pre-treatment with milk, the animals were exposed to γ-rays at 8 Gy or 6 Gy, after which they were evaluated over time for mortality. Average life span of the animal subjects fed with S100 Milk was 24.8 days, which was longer than that of the control group by 16.8 days (Fig. 4). In addition, the activity of phagocytes in gut-associated lymphoid tissue (GALT) was increased, while the number of Enterobacteriaceae was reduced (Table 2). The results clearly demonstrate that S100 Milk enhances the ability of GALT to defend against harmful intestinal bacteria, and to significantly reduce radiation-induced mortality in animal subjects.

(Solid line) 8 Gyirradiation and (Dotted line) 6 Gyirradiation are treatment groups.
(Solid line) 8 Gyirradiation and (Dotted line) 6 Gyirradiation are control groups.
Fig. 4 Survival rates of animal subjects exposed to the irradiation shows that survival of treatment group animals was significantly higher than the control group(8). * p<0.01

Means ± SD (log10 )
Control Milk S100 Milk
Small intestine 2.78 ± 1.34 1.33 ± 0.47
Large intestine 3.38 ± 1.23 2.32 ± 0.95
Cecum 3.62 ± 1.39 2.08 ± 0.85

Table 2. The number of Enterobacteriaceae in the intestinal tract of the treatment animal group was significantly lower than the control group(8). * p<0.05

Immune today, healthy everyday.



These statements have not been evaluated by the Food and Drug Administration.

The products mentioned here are not intended to diagnose, treat, cure or prevent any disease.